Navigation Links
AAHFN's 2008 Annual Meeting in Boston Will Be 'Raising the Bar in Heart Failure Care'
Date:9/26/2007

Join the American Association of Heart Failure Nurses in Boston, June

26-28, 2008

BOSTON, Sept. 26 /PRNewswire/ -- The American Association of Heart Failure Nurses (AAHFN) 2008 Annual Meeting "Raising the Bar in Heart Failure Care" is scheduled for Boston, Massachusetts, June 26-28, 2008. The meeting will focus on cutting-edge cardiovascular research and ways to improve patient care.

The compelling agenda and wonderful backdrop of Boston, a city steeped in history and culture, promise to make this AAHFN's best meeting yet.

The Program

This Annual Meeting is designed for anyone with a passion for heart failure patient care, including advanced practice nurses, inpatient/outpatient nurses, home health nurses, clinical directors, cardiac/HF administrators, researchers, educators, students and other healthcare professionals.

Featuring up-to-date information presented by national heart failure experts, the Annual Meeting will help attendees reinforce, apply and expand their knowledge of heart failure physiology and co-morbidities. Attendees will get a chance to explore treatment advances and other topics on the cutting edge of cardiovascular research to "raise the bar in heart failure care."

The 2008 meeting will be an event to remember featuring leaders in heart failure, cutting-edge educational sessions, significant networking opportunities and unopposed exhibitor hours. Details will soon be available at: http://aahfn.org/annualmeeting/.

The Setting

Boston is a leading destination for travelers, offering history, culture and a beautiful waterfront area. From its revolutionary history to distinct neighborhoods and ethnic foods, Boston is a city of endless activities and exploration.

The Westin Boston Waterfront offers visitors panoramic views of the harbor and the downtown city skyline, as well as proximity to Boston H
'/>"/>

SOURCE American Association of Heart Failure Nurses
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Annual PSA screening reduces risk of prostate cancer deaths
2. Low turnover by Diabetics for free annual checkup
3. UK Spends ?7.3 Billion Annually On Malnutrition Cost
4. Annual Dental Checkups in Children Lagging Behind
5. Annual Budget 2006: Health And Education Sector Receive A Boost
6. Breast cancer survivors slacken on mandated annual mammograms
7. Brazil & Kenya Seek Support For A New Resolution At WHO’s Annual Mee
8. Medical Tourism can Fetch Rs.100 bn Annually by 2012
9. Annual Conference Of Plastic Surgeons In US To Focus On The Future Of Plastic Surgery
10. Jamaica Sees 1000 New Cases of HIV Annually
11. More Indians Die of Rabies Annually

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...RNewswire/--TheBartleHallConventionCenterwilltempo...-10,whenKansasCityhoststhelatestinaseriesofmassive...iceventhasthepotentialtobethebiggestoneyet,because...weekdaysinsteadofoveraweekend,"SheriWood,executive...toftheNationalAssociationofFreeClinics(NAFC). ,...
(Date:11/25/2009)...re/-SentinelleMedicalInc.,aleadingmanufacturerofbr...esasuiteofnewleadingedgeclinicalapplicationsonitsA...RadiologicalSocietyofNorthAmerica(RSNA)annualmeeti...applicationsleveragetheuniquehighqualityimagesgene...pportmultipleimagingmodalitiesformulti-parametrica...
(Date:11/25/2009)...swire-USNewswire/--TheBlackAIDSInstituterecentlyhe...ershipfor2010. ,, ThenewBoardMembersareahighlyd...law,finance,governmenthealthprograms,editorial,and...erangeofpersonalbackgroundsincludingbothheterosexu...es,andrepresentingmultipleagegroups. ,, (Photo:...
(Date:11/25/2009)...ular cancer who were treated with cisplatin-based ...ng neurological side effects and Raynaud-like phen...rapy, according to a new study published online No...nstitute . , Marianne Brydy, M.D., of the Depart...n Bergen, Norway, and colleagues conducted a cross...
(Date:11/25/2009)...essure? This simple question has been the focus o...ated gene Modulates High Blood Pressure in Mice & ...imple question has been the focus of intense resea...first time established a link between a novel gene...ress in mice as well as humans. The studies were d...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
... at reducing problems in heart transplant patients...y the drug reduced the incidence of a serious diso...wn as coronary vasculopathy.// Previous studi... University in Philadelphia conducted a study to d...
...nerable to serious brain injuries when they fall t...tigators distinguish between accidental and intent...a study found that rotational forces generated by ...issue and alter brain function, and nerve cell dam...
...ly common procedure for hard-to-treat cancers. The...take months or even years for stem cells// to beco...is at risk for serious infection. Now, researchers...experimental treatment. In Ed Bauters case...
...t sperm as they get older //and they found to thei...perm an edge. The deformed sperm increase the r...less are likely to beat out their healthy counterp...e is more common in children born to older fathers...
...thma attacks be causing the very thing it aims to ... School of Public Health and Brigham and Women’s H...wn as beta-agonists in asthmatics. Beta-ago...pill or liquid form, delivered in a nebulizer, or ...
...ath rate from it is falling due to early detection...versity of Southern Denmark carried out an analysi...ween 1993 and 1999. While the proportion of pe...Commenting on the findings published in this week'...
Other Medicine News:
(Date:11/25/2009)...inker.comannouncesthatanewmarketresearchreportisav...ry-USMarketTrends&Analysis http://www.reportl...arket-Trends--Analysis.html ,, TheUSintranasal...uticapplicationsfromthedeliveryofconventionallocal...drugs.Thefutureofthetechnologyhingesontotheeffecti...
(Date:11/25/2009)...re/-- ChemoCentryx,Inc.,announcedtodaythatPhaseII...ectiveRandomizedOralTherapyEvaluationinCrohn,sdise...moderate-to-severeCrohn,sdiseasedemonstratedclinic...le.Thestudydemonstratedevidenceofclinicalefficacyi...decreaseintheCrohn,sDiseaseActivityIndex(CDAI)inpa...
(Date:11/24/2009)...stCall/--Endologix,Inc.(Nasdaq: ELGX ),developerof...uncedtodaythatithasfiledamotiontostay,ordiscontinu...ghtagainstitinOctober2009byCook,Inc.Themotionwasfi...diana. ,, Endologixhasrequestedthatthestayremai...ice(USPTO)conductsproceedingstore-examinethetwopat...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 1Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 1National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 2National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 4National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 5Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 1Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 2Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 3Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 4Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 5Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 6Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 7Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 8Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 9Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 10
...linical program to evaluate PROMUS(TM) Element(TM)...3 Boston Scientific Corporation (NYSE: BSX ) to...in the PLATINUM clinical trial, which is designed ...verolimus-Eluting Coronary Stent. The first U.S. ...er of the Rockies in Loveland, Colorado by Thomas ...
...NG-WEIHENSTEPHAN, Germany, February 3 Pieris AG, ...R), a novel class of targeted,human protein therap...,progress in the development of its Anticalin(R) c...oad therapeutic applicability. , Having succes...in vitro,and in vivo, Pieris has now validated the...
Other Medicine Technology:Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 2Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 3Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 4Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 5Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist 2Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist 3
Alkaline Phosphatase
Uric Acid (Uricase) (Single Reagent)
Uric acid FS TBHBA
Uric Acid
Medicine Products: